Accendra HealthACH +2.24%57 Market Cap is $245 Mil as of Jun. 25, 2026. GuruFocus rates ACH with a GF Score™ of 57/100 and a GF Value™ of $5.02 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 122 Medical Distribution companies, Accendra Health ranks better than 59.84% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Accendra Health's share price for the quarter that ended in Mar. 2026 was $2.28. Accendra Health's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 77 Mil. Therefore, Accendra Health's market cap for the quarter that ended in Mar. 2026 was $175 Mil.
Accendra Health's quarterly market cap
declined
from Sep. 2025 ($371 Mil) to Dec. 2025 ($214 Mil) and
declined
from Dec. 2025 ($214 Mil) to Mar. 2026 ($175 Mil).
Accendra Health's annual market cap
declined
from Dec. 2023 ($1,475 Mil) to Dec. 2024 ($1,009 Mil) and
declined
from Dec. 2024 ($1,009 Mil) to Dec. 2025 ($214 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Accendra Health's Enterprise Value for Today is $2,079 Mil.
Accendra Health (NYSE:ACH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Accendra Health Market Cap Related Terms
Accendra Health Market Cap Historical Data
* Premium members only.
The historical data trend for Accendra Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Accendra Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Accendra Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Accendra Health's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health (ACH) has a Market Cap of $245 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Accendra Health and its competitors. According to the industry distribution chart, Accendra Health ranks #49 out of 122 companies in the Medical Distribution industry, placing it in the top 40.2%.
Is Accendra Health's Market Cap too high?
Accendra Health's current Market Cap is $245 Mil. The Medical Distribution industry median Market Cap is 139.40. Accendra Health's value of $245 Mil is 75.8% above this industry median. Based on the distribution chart, Accendra Health ranks #49 out of 122 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Market Cap compare to EDAP and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #49 out of 122 companies for Market Cap. This puts Accendra Health in the upper half of its industry. The industry median Market Cap is 139.40. Accendra Health's value of $245 Mil is 75.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 139.40, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accendra Health's current Market Cap of $245 Mil is 75.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median Market Cap is 139.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current Market Cap is $245 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.20 — trading 36.3% below its estimated fair value. The current Market Cap is $245 Mil and 75.8% above the Medical Distribution industry median of 139.40. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Accendra Health (ACH), the current Market Cap is $245 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.20 is trading 36.3% below its estimated GF Value™ of $5.02.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
Market Cap: $245 Mil
GF Value™: $5.02 vs. price of $3.20 (36.3% below fair value)
Industry Position: 75.8% above the Medical Distribution median (#49 of 122)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score
Get the complete analysis for ACH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 
